
Apollo Hospitals (APOLLOHOSP) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
55.9B
Gross Profit
26.6B
47.63%
Operating Income
5.6B
9.99%
Net Income
4.1B
7.41%
Balance Sheet Metrics
Total Assets
206.6B
Total Liabilities
120.0B
Shareholders Equity
86.5B
Debt to Equity
1.39
Cash Flow Metrics
Revenue & Profitability Trend
Apollo Hospitals Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 217.9B | 188.6B | 164.4B | 145.4B | 104.7B |
Cost of Goods Sold | 113.1B | 98.1B | 85.7B | 75.7B | 56.8B |
Gross Profit | 104.8B | 90.6B | 78.7B | 69.6B | 47.8B |
Gross Margin % | 48.1% | 48.0% | 47.9% | 47.9% | 45.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 25.5B | 21.3B | 15.8B | 9.2B |
Other Operating Expenses | 46.9B | 16.6B | 15.2B | 14.3B | 11.5B |
Total Operating Expenses | 46.9B | 42.1B | 36.5B | 30.1B | 20.7B |
Operating Income | 22.6B | 17.1B | 14.5B | 15.9B | 5.7B |
Operating Margin % | 10.4% | 9.1% | 8.8% | 10.9% | 5.4% |
Non-Operating Items | |||||
Interest Income | - | 429.0M | 445.0M | 351.0M | 218.0M |
Interest Expense | 4.6B | 3.5B | 3.1B | 3.3B | 4.1B |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 20.4B | 13.6B | 11.4B | 15.8B | 2.2B |
Income Tax | 5.3B | 4.5B | 2.6B | 4.8B | 847.0M |
Effective Tax Rate % | 26.2% | 32.7% | 22.4% | 30.2% | 38.4% |
Net Income | 15.1B | 9.4B | 8.4B | 11.1B | 1.4B |
Net Margin % | 6.9% | 5.0% | 5.1% | 7.6% | 1.3% |
Key Metrics | |||||
EBITDA | 32.6B | 23.7B | 20.6B | 21.9B | 11.3B |
EPS (Basic) | ₹100.56 | ₹62.50 | ₹56.97 | ₹73.42 | ₹10.74 |
EPS (Diluted) | ₹100.56 | ₹62.50 | ₹56.97 | ₹73.42 | ₹10.74 |
Basic Shares Outstanding | 143784805 | 143784657 | 143784657 | 143784657 | 139993230 |
Diluted Shares Outstanding | 143784805 | 143784657 | 143784657 | 143784657 | 139993230 |
Income Statement Trend
Apollo Hospitals Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.8B | 5.1B | 4.3B | 5.5B | 4.3B |
Short-term Investments | 24.0B | 6.8B | 2.9B | 5.0B | 10.0B |
Accounts Receivable | 30.2B | 25.1B | 22.3B | 17.6B | 13.3B |
Inventory | 4.8B | 4.6B | 3.9B | 4.3B | 2.5B |
Other Current Assets | 3.8B | 59.0M | 218.0M | 223.0M | 1.7B |
Total Current Assets | 70.3B | 52.8B | 43.4B | 40.6B | 36.4B |
Non-Current Assets | |||||
Property, Plant & Equipment | 98.2B | 36.1B | 31.6B | 29.6B | 24.8B |
Goodwill | 23.5B | 21.6B | 20.8B | 19.9B | 8.4B |
Intangible Assets | 2.9B | 1.4B | 1.1B | 1.1B | 858.0M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 2.0B | 30.0M | 56.0M | 69.0M | 12.0M |
Total Non-Current Assets | 136.3B | 114.7B | 100.9B | 92.1B | 77.8B |
Total Assets | 206.6B | 167.5B | 144.3B | 132.7B | 114.2B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 22.4B | 23.7B | 19.2B | 16.3B | 11.6B |
Short-term Debt | 10.3B | 11.2B | 9.0B | 3.1B | 4.6B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 2.6B | 1.0B | 1.0B | 861.0M | 495.0M |
Total Current Liabilities | 45.8B | 46.6B | 33.2B | 24.3B | 20.4B |
Non-Current Liabilities | |||||
Long-term Debt | 68.3B | 42.2B | 34.4B | 37.6B | 37.0B |
Deferred Tax Liabilities | 4.6B | 4.5B | 4.4B | 5.3B | 2.6B |
Other Non-Current Liabilities | 168.0M | 178.0M | 197.0M | 191.0M | 1.0M |
Total Non-Current Liabilities | 74.3B | 47.7B | 45.7B | 49.3B | 45.8B |
Total Liabilities | 120.0B | 94.3B | 79.0B | 73.7B | 66.1B |
Equity | |||||
Common Stock | 719.0M | 719.0M | 719.0M | 719.0M | 719.0M |
Retained Earnings | - | 27.7B | 20.6B | 16.7B | 5.9B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 86.5B | 73.2B | 65.3B | 59.0B | 48.0B |
Key Metrics | |||||
Total Debt | 78.6B | 53.3B | 43.3B | 40.7B | 41.6B |
Working Capital | 24.5B | 6.2B | 10.1B | 16.3B | 16.0B |
Balance Sheet Composition
Apollo Hospitals Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 15.1B | 9.4B | 8.4B | 11.1B | 1.4B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 1.1B | 875.0M | 760.0M | 26.0M | 32.0M |
Working Capital Changes | -5.2B | -6.4B | -7.5B | -6.0B | -3.7B |
Operating Cash Flow | 15.2B | 7.9B | 5.1B | 9.2B | 1.7B |
Investing Activities | |||||
Capital Expenditures | -17.0B | -11.3B | -11.2B | -6.5B | -2.8B |
Acquisitions | 0 | -37.0M | -499.0M | -1.0B | 5.2B |
Investment Purchases | -35.7B | -12.6B | -9.9B | -15.4B | -16.1B |
Investment Sales | 18.2B | 8.2B | 12.5B | 14.0B | 4.7B |
Investing Cash Flow | -34.5B | -15.8B | -9.2B | -8.9B | -3.6B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -2.7B | -2.2B | -2.6B | -433.0M | -383.0M |
Debt Issuance | 25.9B | 7.1B | 5.8B | 4.3B | 4.8B |
Debt Repayment | -4.4B | -2.5B | -5.2B | -7.4B | -13.8B |
Financing Cash Flow | 19.1B | 2.3B | -1.8B | -3.6B | 2.1B |
Free Cash Flow | 4.2B | 7.8B | 2.5B | 10.4B | 9.7B |
Net Change in Cash | -172.0M | -5.6B | -5.9B | -3.3B | 207.0M |
Cash Flow Trend
Apollo Hospitals Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
70.42
Forward P/E
86.82
Price to Book
12.40
Price to Sales
4.67
PEG Ratio
86.82
Profitability Ratios
Profit Margin
6.63%
Operating Margin
10.20%
Return on Equity
18.85%
Return on Assets
7.60%
Financial Health
Current Ratio
1.54
Debt to Equity
90.89
Beta
0.16
Per Share Data
EPS (TTM)
₹100.60
Book Value per Share
₹571.15
Revenue per Share
₹1,515.74
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
apollohosp | 1.0T | 70.42 | 12.40 | 18.85% | 6.63% | 90.89 |
Max Healthcare | 1.2T | 113.62 | 12.91 | 12.10% | 15.31% | 32.09 |
Fortis Healthcare | 677.5B | 78.10 | 7.60 | 9.13% | 9.94% | 26.99 |
Global Health | 382.5B | 71.45 | 11.30 | 15.30% | 13.04% | 21.19 |
Narayana Hrudayalaya | 352.8B | 45.04 | 9.73 | 21.78% | 13.82% | 66.93 |
Aster DM Healthcare | 300.0B | 91.70 | 8.42 | 147.28% | 7.55% | 55.26 |
Financial data is updated regularly. All figures are in the company's reporting currency.